RÉSUMÉ
Abstract In the present work, twelve bacilli were isolated from four different regions of human skin from Bela population of Nagpur district, India. The isolated bacilli were identified by their morphological, cultural and biochemical characteristics. Seven isolates were Gram negative rods, out of which five were belong to genus Pseudomonas. Three among the five Gram positive isolates were identified as Dermabactor and the remaining two Bacillus. Their antimicrobial susceptibility profile was determined by Kirby-Bauer disc diffusion method. The isolates showed resistance to several currently used broad-spectrum antibiotics. The Dermabactor genus was resistant to vancomycin, although it was earlier reported to be susceptible. Imipenem was found to be the most effective antibiotic for Pseudomonas while nalidixic acid, ampicillin and tetracycline were ineffective. Isolates of Bacillus displayed resistance to the extended spectrum antibiotics cephalosporin and ceftazidime. Imipenem, carbenicillin and ticarcillin were found to be the most effective antibiotics as all the investigated isolates were susceptible to them. Antibiotic resistance may be due to the overuse or misuse of antibiotics during the treatment, or following constant exposure to antibiotic-containing cosmetic formulations.
Sujet(s)
Adolescent/classification , Adolescent/effets des médicaments et des substances chimiques , Adolescent/génétique , Adolescent/isolement et purification , Adolescent/microbiologie , Adolescent/pharmacologie , Adulte/classification , Adulte/effets des médicaments et des substances chimiques , Adulte/génétique , Adulte/isolement et purification , Adulte/microbiologie , Adulte/pharmacologie , Antibactériens/classification , Antibactériens/effets des médicaments et des substances chimiques , Antibactériens/génétique , Antibactériens/isolement et purification , Antibactériens/microbiologie , Antibactériens/pharmacologie , Bacillus/classification , Bacillus/effets des médicaments et des substances chimiques , Bacillus/génétique , Bacillus/isolement et purification , Bacillus/microbiologie , Bacillus/pharmacologie , Femelle/classification , Femelle/effets des médicaments et des substances chimiques , Femelle/génétique , Femelle/isolement et purification , Femelle/microbiologie , Femelle/pharmacologie , Volontaires sains/classification , Volontaires sains/effets des médicaments et des substances chimiques , Volontaires sains/génétique , Volontaires sains/isolement et purification , Volontaires sains/microbiologie , Volontaires sains/pharmacologie , Humains/classification , Humains/effets des médicaments et des substances chimiques , Humains/génétique , Humains/isolement et purification , Humains/microbiologie , Humains/pharmacologie , Mâle/classification , Mâle/effets des médicaments et des substances chimiques , Mâle/génétique , Mâle/isolement et purification , Mâle/microbiologie , Mâle/pharmacologie , Tests de sensibilité microbienne/classification , Tests de sensibilité microbienne/effets des médicaments et des substances chimiques , Tests de sensibilité microbienne/génétique , Tests de sensibilité microbienne/isolement et purification , Tests de sensibilité microbienne/microbiologie , Tests de sensibilité microbienne/pharmacologie , Adulte d'âge moyen/classification , Adulte d'âge moyen/effets des médicaments et des substances chimiques , Adulte d'âge moyen/génétique , Adulte d'âge moyen/isolement et purification , Adulte d'âge moyen/microbiologie , Adulte d'âge moyen/pharmacologie , Peau/classification , Peau/effets des médicaments et des substances chimiques , Peau/génétique , Peau/isolement et purification , Peau/microbiologie , Peau/pharmacologie , Jeune adulte/classification , Jeune adulte/effets des médicaments et des substances chimiques , Jeune adulte/génétique , Jeune adulte/isolement et purification , Jeune adulte/microbiologie , Jeune adulte/pharmacologieRÉSUMÉ
The bacterium, Inquilinus limosus, with its remarkable antimicrobial multiresistant profile, has increasingly been isolated in cystic fibrosis patients. We report draft genome sequence of a strain MP06, which is of considerable interest in elucidating the associated mechanisms of antibiotic resistance in this bacterium and for an insight about its persistence in airways of these patients.
Sujet(s)
Antibactériens/effets des médicaments et des substances chimiques , Antibactériens/génétique , Antibactériens/microbiologie , Antibactériens/pharmacologie , Séquence nucléotidique/effets des médicaments et des substances chimiques , Séquence nucléotidique/génétique , Séquence nucléotidique/microbiologie , Séquence nucléotidique/pharmacologie , Multirésistance bactérienne aux médicaments/effets des médicaments et des substances chimiques , Multirésistance bactérienne aux médicaments/génétique , Multirésistance bactérienne aux médicaments/microbiologie , Multirésistance bactérienne aux médicaments/pharmacologie , Génome bactérien/effets des médicaments et des substances chimiques , Génome bactérien/génétique , Génome bactérien/microbiologie , Génome bactérien/pharmacologie , Infections bactériennes à Gram négatif/effets des médicaments et des substances chimiques , Infections bactériennes à Gram négatif/génétique , Infections bactériennes à Gram négatif/microbiologie , Infections bactériennes à Gram négatif/pharmacologie , Humains/effets des médicaments et des substances chimiques , Humains/génétique , Humains/microbiologie , Humains/pharmacologie , Données de séquences moléculaires/effets des médicaments et des substances chimiques , Données de séquences moléculaires/génétique , Données de séquences moléculaires/microbiologie , Données de séquences moléculaires/pharmacologie , Rhodospirillaceae/effets des médicaments et des substances chimiques , Rhodospirillaceae/génétique , Rhodospirillaceae/microbiologie , Rhodospirillaceae/pharmacologieRÉSUMÉ
Abstract Acinetobacter baumannii is a frequently isolated etiologic agent of nosocomial infections, especially in intensive care units. With the increase in multi-drug resistance of A. baumannii isolates, finding appropriate treatment alternatives for infections caused by these bacteria has become more difficult, and available alternate treatments include the use of older antibiotics such as colistin or a combination of antibiotics. The current study aimed to evaluate the in vitro efficacy of various antibiotic combinations against multi-drug resistant A. baumannii strains. Thirty multi-drug and carbapenem resistant A. baumannii strains isolated at the Ankara Training and Research Hospital between June 2011 and June 2012 were used in the study. Antibiotic susceptibility tests and species-level identification were performed using conventional methods and the VITEK 2 system. The effects of meropenem, ciprofloxacin, amikacin, tigecycline, and colistin alone and in combination with sulbactam against the isolates were studied using Etest (bioMérieux) in Mueller-Hinton agar medium. Fractional inhibitory concentration index (FIC) was used to determine the efficacy of the various combinations. While all combinations showed a predominant indifferent effect, a synergistic effect was also observed in 4 of the 5 combinations. Synergy was demonstrated in 43% of the isolates with the meropenem-sulbactam combination, in 27% of the isolates with tigecycline-sulbactam, and in 17% of the isolates with colistin-sulbactam and amikacin-sulbactam. No synergy was detected with the sulbactam-ciprofloxacin combination and antagonism was detected only in the sulbactam-colistin combination (6.66% of the isolates). Antibiotic combinations can be used as an alternative treatment approach in multi-drug resistant A. baumannii infections.
Sujet(s)
Infections à Acinetobacter/effets des médicaments et des substances chimiques , Infections à Acinetobacter/croissance et développement , Infections à Acinetobacter/microbiologie , Infections à Acinetobacter/pharmacologie , Acinetobacter baumannii/effets des médicaments et des substances chimiques , Acinetobacter baumannii/croissance et développement , Acinetobacter baumannii/microbiologie , Acinetobacter baumannii/pharmacologie , Antibactériens/effets des médicaments et des substances chimiques , Antibactériens/croissance et développement , Antibactériens/microbiologie , Antibactériens/pharmacologie , Multirésistance bactérienne aux médicaments/effets des médicaments et des substances chimiques , Multirésistance bactérienne aux médicaments/croissance et développement , Multirésistance bactérienne aux médicaments/microbiologie , Multirésistance bactérienne aux médicaments/pharmacologie , Synergie des médicaments/effets des médicaments et des substances chimiques , Synergie des médicaments/croissance et développement , Synergie des médicaments/microbiologie , Synergie des médicaments/pharmacologie , Humains/effets des médicaments et des substances chimiques , Humains/croissance et développement , Humains/microbiologie , Humains/pharmacologie , Tests de sensibilité microbienne/effets des médicaments et des substances chimiques , Tests de sensibilité microbienne/croissance et développement , Tests de sensibilité microbienne/microbiologie , Tests de sensibilité microbienne/pharmacologie , Sulbactam/effets des médicaments et des substances chimiques , Sulbactam/croissance et développement , Sulbactam/microbiologie , Sulbactam/pharmacologieRÉSUMÉ
The use of mouthwashes in critical patients has been a source of concern for health professionals due to the diverse range of products, causing uncertainty about which is the most indicated. This study aimed to assess the susceptibility of Staphylococcus spp. isolated in the saliva of individuals from the community and patients in Intensive Care Units (ICU) as to antiseptic mouthwashes. The following oral antiseptics were assessed: cetylpyridinium chloride solution, Listerine® and Neen®. Calcium alginate swab was used for saliva collection to isolate Staphylococcus spp. Microbiological processing involved growth, isolation, strain identification and determination of MID (maximum inhibitory dilution). MID was considered the greatest dilution that completely inhibited the strains. The products efficacy was analyzed by a two-factor ANOVA repeated measures and by Bonferroni adjustments in multiple comparisons, considering a significance level of α=0.05. In total, 80 strains of Staphylococcus spp. were isolated, 40 from ICU patients and 40 from community individuals. MID results revealed that cetylpyridinium chloride solution presented better results in comparison to other products, that is, 39 (97.5 percent) strains from hospital patients with MID 1:128, and 37 (92.5 percent) of individuals from the community had MID 1:64. Neen® inhibited all strains in both groups at a dilution from 1:2 to 1:4. Listerine® presented the worst MID results, 65 percent of the strains from individuals from the community and 10 percent of hospital strains were not inhibited at a dilution of 1:2.
O uso de antissépticos bucais tem sido uma das preocupações dos profissionais de saúde considerando a diversidade de produtos, o que traz a insegurança sobre qual é o mais adequado. Objetivou-se avaliar a suscetibilidade de Staphylococcus spp. isolado da saliva de indivíduos adultos da comunidade e do hospital frente a antissépticos bucais. Os antissépticos avaliados foram: solução de Cloreto de Cetilpiridínio, Listerine® e Neen®. Na coleta de saliva para o isolamento do Staphylococcus spp. utilizou-se o swab de alginato de cálcio. O processamento microbiológico envolveu o crescimento, isolamento, identificação das cepas, determinação da DIM. Foi considerada DIM a maior diluição que inibiu completamente as cepas. A eficácia dos produtos foi avaliada por meio da análise de variância (ANOVA) bilateral com medidas repetidas, e pelo método de ajuste de Bonferroni nas comparações múltiplas, com um nível de significância α=0,05. Totalizou-se 80 cepas de Staphylococcus spp. sendo 40 isoladas de pacientes da UTI e 40 de indivíduos da comunidade. Comparando os resultados é possível verificar que a solução de cloreto de cetilpiridínio apresentou melhores resultados em relação aos demais produtos, ou seja, 39 (97,5 por cento) das cepas hospitalares DIM 1:128 e da comunidade 37 (92,5 por cento) DIM 1:64. Para Neen® nos dois grupos a DIM foi de 1:2 e 1:4. Listerine® apresentou o pior resultado em termos da DIM, sendo que 65 por cento das cepas da comunidade e 10 por cento hospitalar não foram inibidas na diluição 1:2.